Other Announcements & Disclosures

Biocon / Investor Relations / Stock Exchange Disclosures / Other Announcements & Disclosures

Jan-21
21-Jan	Outcome of Board Meeting – Financial Results Q3 FY21 for the quarter and nine months ended December 31, 2020
Dec-20
09-Dec	Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Oct-20
22-Oct	Outcome of Board Meeting – Financial Results for the quarter and half year ended September 30, 2020
Sep-20
22-Sep	Appointment of Mr. Anupam Jindal as Chief Financial Officer and Step down of Mr. Indranil Sen as Interim CFO
03-Sep	Allotment of shares by BBIL to Tata Capital
Aug-20
21-Aug	Intimation pursuant to Regulation 30 of SEBI Listing Regulations, amendment in Memorandum of Association of the Company
Jul-20
25-Jul	Voting results and scrutinizers’ report of the 42nd Annual General Meeting (‘AGM’) of Biocon Limited (‘the Company’)
25-Jul	Proceedings of the 42nd Annual General Meeting (‘AGM’) of Biocon Limited (‘the Company’)
23-Jul	Outcome of the Board Meeting
02-Jul	Notice of 42nd Annual General Meeting and the Annual Report for the FY 2019-20.
May-20
14-May	Outcome of the Board Meeting
14-May	Appointment of Interim Chief Financial Officer (‘Interim CFO’) and Key Managerial Personnel of the Company
Jan-20
23-Jan	Outcome of the Board Meeting